iBIO: Illinois Biotechnology Industry Organization

iBIO’s mission is to make Illinois and the surrounding Midwest one of the world’s top life sciences centers: a great place to do business, and a great place to grow new technology ventures. iBIO advocates for sound public policy, delivers education and training programs, and improves our ability to create, attract, and retain businesses.

Recent News

ATryn* (antithrombin alfa) BLA Filing Accepted By FDA
October 06, 2008
OVATION Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for ATryn*.

OVATION Pharmaceuticals Acquires Rights To Commercialize Xenazine® In U.S. For Chorea Associated With Huntington's Disease
October 01, 2008
OVATION Pharmaceuticals, Inc. announced today that it has acquired from Prestwick Pharmaceuticals the exclusive license in the United States to commercialize Xenazine®.

iBIO President’s - President's Letter – September 2008
September 30, 2008
Before the Fall (Disappears)

More iBIO News

Upcoming Events

BioExec Institute
10/08/2008 – 12/09/2008
Berkeley, CA

Encyclopedia of Life (EOL): Integrating Biodiversity and Information Technology
10/14/2008
Chicago, IL

More Upcoming Events

Leadership Sponsors